4,5,6,7-Tetrahydro-benzothiazol-2-ylamine
CAS : 2933-29-1
Ref. 3D-FT13109
1g | Arrêté | ||
2g | Arrêté | ||
5g | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- (4,5,6,7-Tetrahydro-1,3-benzothiazol-2-yl)amine
- (4,5,6,7-Tetrahydrobenzothiazol-2-yl)amine
- 2(3H)-benzothiazolimine, 4,5,6,7-tetrahydro-
- 2-Amino-4,5,6,7-tetrahydrobenzothiazole
- 2-Amino-4,5-tetramethylenethiazole
- 2-Benzothiazolamine, 4,5,6,7-Tetrahydro-
- 4,5,6,7-Tetrahydro-1,3-benzothiazol-2(3H)-imine
- 4,5,6,7-Tetrahydro-1,3-benzothiazole-2-amine
- 4,5,6,7-Tetrahydro-2-benzothiazolamine
- 4,5,6,7-Tetrahydrobenzo[d]thiazol-2-amine
- Voir d'autres synonymes
- 4,5,6,7-Tetrahydrobenzothiazol-2-amine
- 5,6,7,8-Tetrahydrobenzothiazole-2-amine
- Benzothiazole, 2-amino-4,5,6,7-tetrahydro-
- NSC 45351
- 4,5,6,7-Tetrahydro-1,3-benzothiazol-2-amine
4,5,6,7-Tetrahydro-benzothiazol-2-ylamine is a heterobicyclic compound that is used as a pharmaceutical drug. It has been shown to have antidepressant and neuroprotective effects in animal studies. 4,5,6,7-Tetrahydro-benzothiazol-2-ylamine binds to the dopamine D3 receptor with high selectivity and modulates its activity in the central nervous system. This drug also improves depression and neurodegenerative diseases by increasing dopamine levels in the brain.